Farther Finance Advisors’s Zenas BioPharma ZBIO Stock Holding History

Farther Finance Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27	Buy	+1	New	+$31	﹤0.01%	6059
2026 Q1	–	Sell	-86	Closed	-$3.12K	–	5924
2025 Q4	$3.12K	Buy	86 +62	+258%	+$2.04K	﹤0.01%	4520
2025 Q3	$533	Buy	+24	New	+$391	﹤0.01%	4529

Other funds holding ZBIO

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's ZBIO Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Zenas BioPharma (ZBIO) in Q3 2026: 1 share worth $27. The stake represents ﹤0.01% of the portfolio and ranks #6059 among its holdings. This is a return to the name: Farther Finance Advisors previously reported a position in ZBIO as recently as Q4 2025.

Farther Finance Advisors first reported a position in ZBIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.12K in Q4 2025. 3 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

Farther Finance Advisors held 1 share of Zenas BioPharma worth $27 as of Q3 2026.
Zenas BioPharma was a new Farther Finance Advisors position in Q3 2026.
Zenas BioPharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6059 holding.
Farther Finance Advisors first reported a position in Zenas BioPharma in Q3 2025 and has held it in 3 quarters since.
Farther Finance Advisors's Zenas BioPharma position peaked at $3.12K in Q4 2025.
3 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.